GSL contributes to new Ebola Clinical Guidelines published in The Lancet

October 17, 2017
On October 17th, The Lancet published a manuscript titled “Evidence-based guidelines for supportive care of patients with Ebola virus disease,” lead by Dr. François Lamontagne and co-authored by GSL Director Steven Hoffman, which outlines new Ebola clinical management guidelines. The publication is the result of a Canadian Institutes of Health Research (CIHR) funded project that worked with the World Health Organization (WHO) to craft evidence-based clinical guidelines for delivering interventions and basic care to patients with Ebola. "Based on scientific evidence, our panel concluded a patient's chances of survival could be improved and the spread of the disease impeded by following standard care protocols adjusted to the specific context of a highly contagious disease," explained Dr. Lamontagne, project lead and professor at the Centre de recherche du CHUS and the Faculty of Medicine and Health Sciences at the Université de Sherbrooke.

Hoffman served as a member on the guidelines development panel as the only lawyer, providing ethical, legal and social perspectives on the guidelines, which will help to inform the way Ebola is clinically managed during future outbreaks. The manuscript details that by delivering certain supportive care interventions, many patients’ lives could be saved. Hoffman notes that "the world is seeing increasing numbers of infectious disease outbreaks, so it’s important that our health professionals are ready to respond to them. These evidence-based guidelines summarize the best available research on how health professionals should manage patients with Ebola virus disease. Their development and publication means that health professionals won’t be scrambling the next time Ebola hits – but will know immediately how to care for patients with the virus.”

Further underscored by Dr. Marc Ouellette, Scientific Director for the CIHR Institute of Infection and Immunity, “the increasing emergence of wide-spread epidemics and various infectious diseases, like that of the Ebola virus, poses significant challenges to the health and safety of people worldwide. The Canadian Institutes of Health Research (CIHR) recognizes the need for continued research to develop tangible, real-world solutions to global health threats. On behalf of CIHR, I congratulate all involved in the work creating these guidelines. They are an important tool to manage the risks associated with treating patients who have contracted the Ebola virus. Through adoption of these guidelines and through research we can help stop the spread of this virus.”
Read the full article here. For media inquiries, please contact Annie Jones at